Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04920708
Title Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression (FAIM)
Acronym FAIM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Royal Marsden NHS Foundation Trust
Age Groups: adult | senior
Covered Countries GBR

No variant requirements are available.